Freedom Broker cuts Salesforce stock price target on AI monetization uncertainty

Freedom Broker cut Salesforce's price target to $230 from $360 while keeping a Buy rating, citing a Q1 FY27 revenue and non-GAAP EPS beat but signs of slowing legacy application growth. Agentforce ARR crossed $1 billion and buybacks remain aggressive via the $25 billion accelerated share repurchase program, but RPO was only in line for a second straight quarter and Q2 guidance points to continued deceleration. The article also notes a mixed analyst backdrop, with several firms lowering targets despite the beat.

Analysis

CRM’s setup is no longer about top-line surprise; it is about whether buybacks and AI monetization can offset a mature core franchise. The aggressive repurchase cadence changes the earnings path mechanically over the next 2-4 quarters, but that support is finite if operating growth keeps slowing, because multiple expansion will require evidence that new products are additive rather than merely replacing legacy seat growth. The market is likely still underestimating how much of the near-term EPS resilience is financial engineering versus durable operating leverage.

The more interesting second-order effect is competitive: if Salesforce’s AI and workflow layer remains under-monetized, the value accrual shifts to adjacent infrastructure and integration layers rather than CRM itself. That creates room for picks-and-shovels beneficiaries tied to data plumbing, model deployment, and enterprise integration, while pressuring incumbents that rely on proving AI consumption before revenue shows up. INFA is a possible beneficiary only if it can sustain its role as a control point in enterprise data motion, but any integration premium may be capped if Salesforce internalizes more of the stack.

Contrarianly, the stock may be less "cheap" than it looks once you adjust for the buyback tailwind and decelerating organic growth. The real catalyst is not the next quarter’s beat; it is whether management can quantify AI consumption monetization over the next 6-12 months, because until then the Rule-of-50 framework is doing most of the valuation heavy lifting. If that proof point slips, the downside is not a collapse in fundamentals but a slow rerating lower as the market stops paying for a future monetization story.

Key Decisions for Investors

• Stay tactically long CRM only via call spreads into the next 1-2 earnings prints; upside is driven by continued buyback support and multiple mean reversion, but cap gains if AI monetization remains vague. Use a 3-6 month horizon and trim if guidance again implies deceleration.
• Consider a relative-value long CRM / short software basket trade against higher-multiple enterprise names with no buyback support; CRM has the cleaner capital-return backstop, but the short leg should be names where growth is still being priced as durable. Reassess if CRM’s organic revenue reaccelerates for two consecutive quarters.
• If looking for AI workflow exposure without paying CRM’s execution premium, pair a small long INFA with a short in a data-platform peer that is more exposed to AI spending delays. This works best over 6-12 months if enterprise AI adoption stays experimental rather than consumptive.
• Avoid chasing the equity on a headline beat alone; wait for either a pullback to the next quarter’s setup or evidence that Agentforce ARR is translating into net new contract value. The risk/reward weakens materially if buybacks slow before monetization inflects.